Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|2|176-191

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.2, 2010-03, pp. : 176-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Targets in Malignant Pleural Mesothelioma Treatment

By  

Current Drug Targets, Vol. 10, Iss. 12, 2009-12 ,pp. : 1235-1244

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation

By  

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3895-3902

Bentham Science Publishers

Access to resources Recommend Favorite

Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines

By de Cupis A.   Semino C.   Pirani P.   Loprevite M.   Ardizzoni A.   Favoni R.E.  

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 83-95

Elsevier

Access to resources Recommend Favorite

Pemetrexed prolongs survival in patients with malignant pleural mesothelioma or non-small-cell lung cancer

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 10, 2005-10 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38MAPK and JNK1/2 but not of ERK1/2

By Posser Thaís   Aguiar Cláudia   Garcez Ricardo   Rossi Francesco   Oliveira Camila   Trentin Andréa   Moura Neto Vivaldo   Leal Rodrigo  

Archives of Toxicology, Vol. 81, Iss. 6, 2007-06 ,pp. : 407-414

Springer Publishing Company

Access to resources Recommend Favorite